• 1
    Fazzalari NL, Moore RJ, Manthey B, Vernon-Roberts B 1992 Comparative study of iliac crest and subchondral femoral bone in osteoarthritic patients. Bone 13:331335.
  • 2
    Crane GJ, Fazzalari NL, Parkinson IH, Vernon-Roberts B 1990 Age-related changes in femoral trabecular bone in arthrosis. Acta Orthopaed Scand 61:421426.
  • 3
    Amir G, Pirie CJ, Rashad S, Revell PA 1992 Remodelling of subchondral bone in osteoarthritis: A histomorphometric study. J Clin Pathol 45:990992.
  • 4
    Bland JH, Cooper SM 1984 Osteoarthritis: A review of the cell biology involved and evidence for reversibility. Management rationally related to known genesis and pathophysiology. Sem Arthritis Rheum 14:106133.
  • 5
    Fazzalari NL, Vernon-Roberts B, Manthey B, Parkinson IH 1990 Relationship between changes in articular cartilage and bone in the femoral head in osteoarthritis of the hip. J Orthopaed Rheumatol 3:155169.
  • 6
    Li B, Aspden RM 1997 Composition and mechanical properties of cancellous bone from the femoral head of patients with osteoporosis or osteoarthritis. J Bone Miner Res 12:641651.
  • 7
    Radin EL, Paul IL, Rose RB 1972 Role of mechanical factors in pathogenesis of primary osteoarthritis. Lancet 1:519520.
  • 8
    Dequeker J, Boonen S, Aerssens J, Westhovens R 1996 Inverse relationship osteoarthritis—osteoporosis: What is the evidence? What are the consequences? Br J Rheumatol 35:813820.
  • 9
    Martin TJ, Ng KW 1994 Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 56:357366.
  • 10
    Martin TJ, Romas E, Gillespie MT 1998 Interleukins in the control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 8:107123.
  • 11
    Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic cell function. Nature 390:175179.
  • 12
    Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS, Frankel WN, Lee SY, Choi Y 1997 TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272:2519025194.
  • 13
    Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165176.
  • 14
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki SI, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:35973602.
  • 15
    Horwood NJ, Elliot J, Martin TJ, Gillespie MT 1998 Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:47434746.
  • 16
    Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan H-L, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ 1999 Tumor necrosis factor receptor member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:35403545.
  • 17
    Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JM, Niforas P, Ng KW, Martin TJ, Gillespie MT 1999 Localization of RANKL (receptor activator of NFkappaB ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 25:525534.
  • 18
    Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J 1999 RANK is essential for osteoclast and lymph node development. Genes Dev 13:24122424.
  • 19
    Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang M-S, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309319.
  • 20
    Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS 1998 Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:12601268.
  • 21
    Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S 1999 Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:43824389.
  • 22
    Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:212.
  • 23
    Fazzalari NL, Darracott J, Vernon-Roberts B 1985 Histomorphometric changes in the trabecular structure of a selected stress region in the femur in patients with osteoarthritis and fracture of the femoral neck. Bone 6:125133.
  • 24
    Collins D 1949 Osteoarthritis. In: The Pathology of Articular and Spinal Diseases. Edward Arnold and Co., London, UK, pp. 74115.
  • 25
    Kuliwaba JS, Findlay DM, Atkins GJ, Forwood MR, Fazzalari NL 2000 Enhanced expression of osteocalcin mRNA in human osteoarthritic trabecular bone of the proximal femur is associated with decreased expression of interleukin-6 and interleukin-11 mRNA. J Bone Miner Res 15:332341.
  • 26
    Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM 2000 Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res 15:640649.
  • 27
    Fazzalari NL, Parkinson IH 1998 Femoral trabecular bone of osteoarthritic and normal subjects in an age and sex matched group. Osteoarthritis Cartilage 6:377382.
  • 28
    Felson DT, Couropmitree NN, Chaisson CE, Hannan MT, Zhang Y, McAlindon TE, LaValley M, Levy D, Myers RH 1998 Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis: The Framingham Study. Arthritis Rheum 41:10641071.
  • 29
    Felson DT, Zhang Y 1998 An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 41:13431355.
  • 30
    Dequeker J, Mohan S, Finkelman RD, Aerssens J, Baylink DJ 1993 Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor β in cortical bone from the iliac crest. Arthritis Rheum 26:17021708.
  • 31
    Nevitt MC, Lane NE, Scott JC, Hochberg MC, Pressman AR, Genant HK, Cummings SR 1995 Radiographic osteoarthritis of the hip and bone mineral density. The study of osteoporotic fractures research group. Arthritis Rheum 38:907916.
  • 32
    Parfitt AM 1994 Osteonal and hemi-osteonal remodeling the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 55:273286.
  • 33
    Boyce RW, Paddock CL, Gleason JR, Sletsema WK, Eriksen EF 1995 The effects of risedronate on canine cancellous bone remodeling: Three-dimensional kinetic reconstruction of the remodeling site. J Bone Miner Res 10:211221.
  • 34
    Takai H, Kanematsu M, Yano K, Tsuda E, Higashio K, Ikeda K, Watanabe K, Yamada YJ 1998 Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. Biol Chem 273:2709127096.